UBS AM’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
300,962
+68,602
| +30% | +$2.49M | ﹤0.01% | 1313 |
|
|
2025
Q1 | $8.41M | Buy |
232,360
+29,984
| +15% | +$1.09M | ﹤0.01% | 1309 |
|
|
2024
Q4 | $8.51M | Buy |
202,376
+24,620
| +14% | +$1.04M | ﹤0.01% | 1326 |
|
|
2024
Q3 | $9.87M | Buy |
177,756
+947
| +0.5% | +$52.6K | ﹤0.01% | 1228 |
|
|
2024
Q2 | $7.27M | Buy |
176,809
+46,549
| +36% | +$1.91M | ﹤0.01% | 1284 |
|
|
2024
Q1 | $6.08M | Buy |
130,260
+12,054
| +10% | +$563K | ﹤0.01% | 1172 |
|
|
2023
Q4 | $5.65M | Buy |
118,206
+3,685
| +3% | +$176K | ﹤0.01% | 1194 |
|
|
2023
Q3 | $4.08M | Buy |
114,521
+8,554
| +8% | +$305K | ﹤0.01% | 1301 |
|
|
2023
Q2 | $4.25M | Hold |
105,967
| – | – | ﹤0.01% | 1312 |
|
|
2023
Q1 | $4.25M | Sell |
105,967
-15,952
| -13% | -$640K | ﹤0.01% | 1312 |
|
|
2022
Q4 | $5.65M | Buy |
121,919
+23,282
| +24% | +$1.08M | ﹤0.01% | 1128 |
|
|
2022
Q3 | $4.08M | Sell |
98,637
-16,039
| -14% | -$664K | ﹤0.01% | 1266 |
|
|
2022
Q2 | $6.84M | Sell |
114,676
-507
| -0.4% | -$30.2K | ﹤0.01% | 1098 |
|
|
2022
Q1 | $8.36M | Buy |
115,183
+11,669
| +11% | +$847K | ﹤0.01% | 1139 |
|
|
2021
Q4 | $8.7M | Buy |
103,514
+10,801
| +12% | +$908K | ﹤0.01% | 1178 |
|
|
2021
Q3 | $8.36M | Sell |
92,713
-2,558
| -3% | -$231K | ﹤0.01% | 1155 |
|
|
2021
Q2 | $9.08M | Buy |
95,271
+22,754
| +31% | +$2.17M | ﹤0.01% | 1152 |
|
|
2021
Q1 | $8.26M | Buy |
72,517
+4,116
| +6% | +$469K | ﹤0.01% | 1144 |
|
|
2020
Q4 | $9.47M | Buy |
68,401
+3,066
| +5% | +$424K | ﹤0.01% | 1075 |
|
|
2020
Q3 | $5.37M | Buy |
65,335
+5,237
| +9% | +$430K | ﹤0.01% | 1124 |
|
|
2020
Q2 | $4.7M | Sell |
60,098
-310
| -0.5% | -$24.2K | ﹤0.01% | 1138 |
|
|
2020
Q1 | $2.68M | Buy |
60,408
+988
| +2% | +$43.9K | ﹤0.01% | 1294 |
|
|
2019
Q4 | $2.54M | Buy |
59,420
+1,336
| +2% | +$57.1K | ﹤0.01% | 1489 |
|
|
2019
Q3 | $2.48M | Buy |
58,084
+9,744
| +20% | +$417K | ﹤0.01% | 1511 |
|
|
2019
Q2 | $3.07M | Buy |
48,340
+4,577
| +10% | +$291K | ﹤0.01% | 1398 |
|
|
2019
Q1 | $3.04M | Buy |
43,763
+8,314
| +23% | +$577K | ﹤0.01% | 1340 |
|
|
2018
Q4 | $1.54M | Buy |
35,449
+1,676
| +5% | +$72.9K | ﹤0.01% | 1543 |
|
|
2018
Q3 | $2.58M | Buy |
33,773
+603
| +2% | +$46K | ﹤0.01% | 1400 |
|
|
2018
Q2 | $2.55M | Sell |
33,170
-260
| -0.8% | -$20K | ﹤0.01% | 1400 |
|
|
2018
Q1 | $1.7M | Buy |
33,430
+6,768
| +25% | +$345K | ﹤0.01% | 1538 |
|
|
2017
Q4 | $1.24M | Buy |
26,662
+1,636
| +7% | +$75.9K | ﹤0.01% | 1652 |
|
|
2017
Q3 | $1.33M | Buy |
25,026
+1,390
| +6% | +$74K | ﹤0.01% | 1580 |
|
|
2017
Q2 | $1.47M | Buy |
23,636
+3,795
| +19% | +$236K | ﹤0.01% | 1487 |
|
|
2017
Q1 | $1.34M | Buy |
19,841
+7,128
| +56% | +$483K | ﹤0.01% | 1513 |
|
|
2016
Q4 | $894K | Sell |
12,713
-8,606
| -40% | -$605K | ﹤0.01% | 1600 |
|
|
2016
Q3 | $1.51M | Buy |
21,319
+1,660
| +8% | +$118K | ﹤0.01% | 1488 |
|
|
2016
Q2 | $962K | Buy |
19,659
+7,492
| +62% | +$367K | ﹤0.01% | 1674 |
|
|
2016
Q1 | $770K | Sell |
12,167
-47,979
| -80% | -$3.04M | ﹤0.01% | 1745 |
|
|
2015
Q4 | $6.75M | Sell |
60,146
-761
| -1% | -$85.4K | 0.01% | 971 |
|
|
2015
Q3 | $5.87M | Buy |
60,907
+51,307
| +534% | +$4.94M | 0.01% | 1008 |
|
|
2015
Q2 | $983K | Buy |
9,600
+1,500
| +19% | +$154K | ﹤0.01% | 1687 |
|
|
2015
Q1 | $503K | Buy |
8,100
+3,500
| +76% | +$217K | ﹤0.01% | 1979 |
|
|
2014
Q4 | $202K | Buy |
+4,600
| New | +$202K | ﹤0.01% | 2465 |
|